On Monday, April 27, 2020, at 3:00 p.m.,the Subcommittees will hold a briefing with the Food and Drug Administration (FDA) to examine the impact of the coronavirus pandemic on the global supply chain for pharmaceuticals sold in the United States, with a particular focus on national security and consumer implications. On March 13, 2020, Representative Chip Roy, Ranking Member Jim Jordan, and Republican Committee Members wrote to ChairwomanMaloney requesting action on this topic.